In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

A hospitalized patient triggers a major setback for Intellia's $1.9B flagship drug, shaking investor faith overnight ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

The news for the chocolate industry is a welcome development, as businesses and scientists grapple with crop shortages.

Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...

Advances in gene editing tools like CRISPR‑Cas9 and pre-implantation embryo screening are turning the idea of designer babies ...

Science isn’t always serious. Sometimes researchers ask questions that seem silly at first, like why toast lands butter-side ...

Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...

A research team has successfully engineered a japonica rice variety using CRISPR/Cas9 to simultaneously optimize plant ...